SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,693 | +5.5% | 96,465 | -0.3% | 0.03% | +8.3% |
Q2 2023 | $11,085 | -13.0% | 96,791 | +4.7% | 0.02% | -17.2% |
Q1 2023 | $12,740 | +5909.4% | 92,434 | +5556.9% | 0.03% | +2800.0% |
Q4 2022 | $212 | -99.8% | 1,634 | +41.6% | 0.00% | – |
Q3 2022 | $128,000 | -93.4% | 1,154 | -95.6% | 0.00% | -100.0% |
Q1 2021 | $1,953,000 | -88.1% | 26,209 | -72.8% | 0.01% | -89.6% |
Q4 2020 | $16,424,000 | -37.7% | 96,335 | -48.7% | 0.05% | +14.3% |
Q3 2020 | $26,372,000 | -22.5% | 187,792 | -11.6% | 0.04% | -28.8% |
Q2 2020 | $34,044,000 | +352.4% | 212,328 | +176.0% | 0.06% | +55.3% |
Q1 2020 | $7,526,000 | -41.7% | 76,934 | -23.1% | 0.04% | -24.0% |
Q4 2019 | $12,909,000 | +69.1% | 100,038 | -1.3% | 0.05% | +38.9% |
Q3 2019 | $7,634,000 | -47.9% | 101,352 | +5.1% | 0.04% | -49.3% |
Q2 2019 | $14,654,000 | -1.8% | 96,440 | -23.0% | 0.07% | -2.7% |
Q1 2019 | $14,927,000 | +10.0% | 125,235 | +0.7% | 0.07% | +7.4% |
Q4 2018 | $13,568,000 | -22.6% | 124,325 | +14.5% | 0.07% | -20.9% |
Q3 2018 | $17,534,000 | – | 108,562 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |